Literature DB >> 12240943

Increasing paracellular porosity by E-cadherin peptides: discovery of bulge and groove regions in the EC1-domain of E-cadherin.

Ernawati Sinaga1, Seetharama D S Jois, Mike Avery, Irwan T Makagiansar, Usman S F Tambunan, Kenneth L Audus, Teruna J Siahaan.   

Abstract

PURPOSE: The objective of this work is to evaluate the ability of peptides derived from the bulge (HAV-peptides) and groove (ADT-peptides) regions of E-cadherin EC1-domain to increase the paracellular porosity of the intercellular junctions of Madin-Darby canine kidney (MDCK) cell monolayers.
METHODS: Peptides were synthesized using a solid-phase method and were purified using semi-preparative HPLC. MDCK monolayers were used to evaluate the ability of cadherin peptides to modulate cadherin-cadherin interactions in the intercellular junctions. The increase in intercellular junction porosity was determined by the change in transepithelial electrical resistance (TEER) values and the paracellular transport of 14C-mannitol.
RESULTS: HAV- and ADT-peptides can lower the TEER value of MDCK cell monolayers and enhance the paracellular permeation of 14C-mannitol. HAV- and ADT-decapeptides can modulate the intercellular junctions when they are added from the basolateral side but not from the apical side; on the other hand. HAV- and ADT-hexapeptides increase the paracellular porosity of the monolayers when added from either side. Conjugation of HAV- and ADT-peptides using omega-aminocaproic acid can only work to modulate the paracellular porosity when ADT-peptide is at the N-terminus and HAV-peptide is at the C-terminus; because of its size, the conjugate can only modulate the intercellular junction when added from the basolateral side.
CONCLUSIONS: Peptides from the bulge and groove regions of the EC1 domain of E-cadherin can inhibit cadherin-cadherin interactions, resulting in the opening of the paracellular junctions. These peptides may be used to improve paracellular permeation of peptides and proteins. Furthermore, this work suggests that both groove and bulge regions of EC-domain are important for cadherin-cadherin interactions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12240943     DOI: 10.1023/a:1019850226631

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

1.  Modulation of cellular adhesion in bovine brain microvessel endothelial cells by a decapeptide.

Authors:  D Pal; K L Audus; T J Siahaan
Journal:  Brain Res       Date:  1997-01-30       Impact factor: 3.252

Review 2.  Cadherins: a molecular family important in selective cell-cell adhesion.

Authors:  M Takeichi
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

Review 3.  Molecular structure of the apical junction complex and its contribution to the paracellular barrier.

Authors:  K L Lutz; T J Siahaan
Journal:  J Pharm Sci       Date:  1997-09       Impact factor: 3.534

Review 4.  Tight junctions and the molecular basis for regulation of paracellular permeability.

Authors:  J M Anderson; C M Van Itallie
Journal:  Am J Physiol       Date:  1995-10

Review 5.  Morphogenetic roles of classic cadherins.

Authors:  M Takeichi
Journal:  Curr Opin Cell Biol       Date:  1995-10       Impact factor: 8.382

6.  Cyclic and acyclic partial retro-inverso enkephalinamides: Mu receptor selective enzyme resistant analogs.

Authors:  J M Berman; M Goodman; T M Nguyen; P W Schiller
Journal:  Biochem Biophys Res Commun       Date:  1983-09-30       Impact factor: 3.575

7.  Tight junction formation in cultured epithelial cells (MDCK).

Authors:  L Gonzalez-Mariscal; B Chávez de Ramírez; M Cereijido
Journal:  J Membr Biol       Date:  1985       Impact factor: 1.843

8.  Antibody recognition of peptide sequences from the cell-cell adhesion proteins: N- and E-cadherins.

Authors:  K L Lutz; L A Szabo; D L Thompson; T J Siahaan
Journal:  Pept Res       Date:  1996 Sep-Oct

9.  Dissociation of Madin-Darby canine kidney epithelial cells by the monoclonal antibody anti-arc-1: mechanistic aspects and identification of the antigen as a component related to uvomorulin.

Authors:  J Behrens; W Birchmeier; S L Goodman; B A Imhof
Journal:  J Cell Biol       Date:  1985-10       Impact factor: 10.539

10.  Soluble E-cadherin fragments increased in circulation of cancer patients.

Authors:  M Katayama; S Hirai; K Kamihagi; K Nakagawa; M Yasumoto; I Kato
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

View more
  15 in total

1.  Effects of an E-cadherin-derived peptide on the gene expression of Caco-2 cells.

Authors:  Anna Maria Calcagno; Jennifer M Fostel; Eric L Reyner; Ernawati Sinaga; James T Alston; William B Mattes; Teruna J Siahaan; Joseph A Ware
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

2.  Improving the stability of the EC1 domain of E-cadherin by thiol alkylation of the cysteine residue.

Authors:  Maulik Trivedi; Jennifer S Laurence; Todd D Williams; C Russell Middaugh; Teruna J Siahaan
Journal:  Int J Pharm       Date:  2012-04-17       Impact factor: 5.875

3.  Modulation of intercellular junctions by cyclic-ADT peptides as a method to reversibly increase blood-brain barrier permeability.

Authors:  Marlyn D Laksitorini; Paul K Kiptoo; Ngoc H On; James A Thliveris; Donald W Miller; Teruna J Siahaan
Journal:  J Pharm Sci       Date:  2015-01-12       Impact factor: 3.534

Review 4.  Pathways and progress in improving drug delivery through the intestinal mucosa and blood-brain barriers.

Authors:  Marlyn Laksitorini; Vivitri D Prasasty; Paul K Kiptoo; Teruna J Siahaan
Journal:  Ther Deliv       Date:  2014-10

5.  Enhancement of drug absorption through the blood-brain barrier and inhibition of intercellular tight junction resealing by E-cadherin peptides.

Authors:  Paul Kiptoo; Ernawati Sinaga; Anna M Calcagno; Hong Zhao; Naoki Kobayashi; Usman S F Tambunan; Teruna J Siahaan
Journal:  Mol Pharm       Date:  2010-12-17       Impact factor: 4.939

6.  Comparison of Linear and Cyclic His-Ala-Val Peptides in Modulating the Blood-Brain Barrier Permeability: Impact on Delivery of Molecules to the Brain.

Authors:  Ahmed Alaofi; Ngoc On; Paul Kiptoo; Todd D Williams; Donald W Miller; Teruna J Siahaan
Journal:  J Pharm Sci       Date:  2016-02       Impact factor: 3.534

7.  A randomly coiled, high-molecular-weight polypeptide exhibits increased paracellular diffusion in vitro and in situ relative to the highly ordered alpha-helix conformer.

Authors:  Nazila Salamat-Miller; Montakarn Chittchang; Ashim K Mitra; Thomas P Johnston
Journal:  Pharm Res       Date:  2005-02       Impact factor: 4.200

8.  Evaluation of the physical stability of the EC5 domain of E-cadherin: effects of pH, temperature, ionic strength, and disulfide bonds.

Authors:  Kai Zheng; C Russell Middaugh; Teruna J Siahaan
Journal:  J Pharm Sci       Date:  2009-01       Impact factor: 3.534

9.  Characterization of multiple stable conformers of the EC5 domain of E-cadherin and the interaction of EC5 with E-cadherin peptides.

Authors:  Kai Zheng; Jennifer S Laurence; Krzysztof Kuczera; Gennady Verkhivker; C Russell Middaugh; Teruna J Siahaan
Journal:  Chem Biol Drug Des       Date:  2009-06       Impact factor: 2.817

10.  Brain Delivery of Drug and MRI Contrast Agent: Detection and Quantitative Determination of Brain Deposition of CPT-Glu Using LC-MS/MS and Gd-DTPA Using Magnetic Resonance Imaging.

Authors:  Kayann Tabanor; Phil Lee; Paul Kiptoo; In-Young Choi; Erica B Sherry; Cheyenne Sun Eagle; Todd D Williams; Teruna J Siahaan
Journal:  Mol Pharm       Date:  2016-01-06       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.